0 Kommentare
0 Geteilt
159 Ansichten
0 Bewertungen
Gesponsert
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Africa Cancer Targeted Therapy Market Worth USD 1.73 Billion in 2024 Witnessing Strong CAGR-led Growth by 2031The Africa cancer targeted therapy market is experiencing significant growth due to the increasing burden of cancer and the rising adoption of precision-based oncology treatments across the region. The Africa Cancer Targeted Therapy Market size is expected to reach US$ 3,477.6 million by 2031 from US$ 1,733.4 million in 2024. The market is estimated to record a CAGR of 10.5% from 2025 to 2031....0 Kommentare 0 Geteilt 695 Ansichten 0 Bewertungen
-
Middle East Cancer Targeted Therapy Market Valued at USD 1.05 Billion in 2024 Strengthened by Advancing Precision Oncology by 2031The Middle East cancer targeted therapy market is witnessing substantial growth due to the increasing prevalence of cancer and the growing adoption of precision medicine across healthcare systems in the region. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9%...0 Kommentare 0 Geteilt 849 Ansichten 0 Bewertungen
-
mTOR Inhibitor Oncology Drug Market Advances with Targeted Cancer Therapy Innovations"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Analysis Report CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period mTOR Inhibitor Oncology Drug Market report objective analysis is...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
South and Central America Cancer Targeted Therapy Market Valued at USD 4.73 Billion in 2024 Strengthened by Advancing Precision Oncology by 2031The South and Central America cancer targeted therapy market is expanding rapidly due to the increasing prevalence of cancer and the growing adoption of precision oncology treatments across the region. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of...0 Kommentare 0 Geteilt 857 Ansichten 0 Bewertungen
-
Wnt Pathway Targeted Therapy Market: Industry Outlook & Forecast 2026–2033"According to the latest report published by Data Bridge Market Research, the Wnt Pathway Targeted Therapy Market The global Wnt Pathway Targeted Therapy market size was valued at USD 812.00 Million in 2025 and is expected to reach USD 4198.97 Million by 2033, at a CAGR of 22.80% during the forecast period All the data and information included in the...0 Kommentare 0 Geteilt 501 Ansichten 0 Bewertungen
-
Adult Malignant Glioma Therapeutics Market Report 2031: Growth Drivers, Opportunities, and Competitive StrategiesThe Adult Malignant Glioma Therapeutics Market is experiencing strong growth due to the rising prevalence of aggressive brain tumors and the increasing demand for advanced treatment options. According to insights from The Insight Partners, the Adult Malignant Glioma Therapeutics Market is projected to reach US$ 5.39 billion by 2031, registering a CAGR of 9.8% during 2025–2031. This growth...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
ASEAN Region Witnesses Rapid Shift Toward Targeted Cancer Treatments, Market to 2031 SurgesCancer targeted therapy refers to a treatment approach that uses drugs or biological agents to specifically identify and attack cancer cells while minimizing damage to healthy tissues. The ASEAN Cancer Targeted Therapy Market size is expected to reach US$ 9,217.7 million by 2031 from US$ 3,422.2 million in 2024. The market is estimated to record a CAGR of 15.2% from 2025 to...0 Kommentare 0 Geteilt 811 Ansichten 0 Bewertungen
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
Weitere Ergebnisse
Gesponsert
Gesponsert
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek